MarginsXMarginsX
Home › Markets › Health Care › CV

CapsoVision Inc. (CV)

CV trades on Nasdaq in Health Care, Biotechnology: Electromedical & Electrotherapeutic Apparatus. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$6.47
+7.30% on the day
Market cap
$346.9M
Small cap
Revenue · 2025
$13.6M
+15.3% on 2024
Net income · 2025
-$25.3M
-186.8% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1378325/000137832526000010/0001378325-26-000010-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerCV on Nasdaq
SectorHealth Care
IndustryBiotechnology: Electromedical & Electrotherapeutic Apparatus
CountryUnited States
IPO year2025
SEC CIK0001378325
SEC industry codeElectromedical & Electrotherapeutic Apparatus
Incorporated inDE

Financials · 2025

LineValue
Revenue$13.6M
Net income-$25.3M
Operating income-$25.5M
Net margin-186.8%
Operating margin-188.3%
Revenue growth+15.3%
CashNot in SEC XBRL data
Total assets$18.2M
P/E (computed)Net income was not positive
P/S (computed)25.6×

Warning signs

Cash runway
not enough data
Share count, 1 year
+14.4%
2025-11-11 to 2026-11-11
Going-concern doubt
Yes
10-Q filed November 12, 2026
Insider net buying, 12 months
$16.0M
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"The Company, having evaluated the extant facts and circumstances, concluded that the facts and circumstances raise substantial doubt about the Company's ability to continue as a going concern within one year after the date of issuance of these financial statements."
10-Q 2026-11-12
Cash and burnnot enough dataReport 2026-09-30
Shares outstanding53,609,719 (2026-11-11); 46,843,225 a year earlier.Cover page 2026-11-11
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months1 S-3/F-3 shelf filings; 2 424B5 takedowns, 2 at the marketLatest 2026-09-18
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorBaker Tilly US, LLP, Santa Clara, California, United StatesPCAOB Form AP 2026-04-22
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $16.0M, sold $9K on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$3.6M-$7.3M-$7.0MNot filedNo debt tags$13.9M10-Q 2026-11-12
Q2 2026
2026-06-30
$3.6M-$7.5M-$8.4MNot filedNo debt tags$13.9M10-Q 2026-08-13
Q1 2026
2026-03-31
$2.8M-$7.0M-$6.1MNot filedNo debt tags$13.6M10-Q 2026-05-14
Q4 2025
2025-12-31
$3.9M-$7.4M-$7.7MNot filedNo debt tags$13.6M10-K 2026-03-26
Q3 2025
2025-09-30
$3.5M-$7.9M-$5.7MNot filedNo debt tags$13.1M10-Q 2026-11-12
Q2 2025
2025-06-30
$3.3M-$4.6M-$4.5MNot filedNo debt tags$12.5M10-Q 2026-08-13
Q1 2025
2025-03-31
$2.8M-$5.4M-$5.0MNot filedNo debt tags$12.0M10-Q 2026-05-14
Q4 2024
2024-12-31
$3.5M-$4.6M-$5.4MNot filedNo debt tags$11.8M10-K 2026-03-26

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B52026-09-18
Latest annual report10-K2026-03-26
Latest quarterly / interim10-Q2026-11-12
Latest current report8-K2026-11-12
Latest proxyDEF 14A2026-04-28

Source: SEC EDGAR submissions feed, 143 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-4.6%
1 month-11.1%
3 months-11.2%
Year to date-43.6%
1 year+6.3%
From 52-week high-58.2%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Electromedical & Electrotherapeutic Apparatus

TickerCompanyPriceDayMarket cap
ELMDElectromed Inc.$23.10-5.02%$188.8M
INMDInMode Ltd.$13.15-0.90%$755.9M
FOCLEDAP TMS S.A.$3.17-2.39%$149.7M
CBLLCeriBell Inc.$26.42+1.07%$1.0B
HSDTSolana Company Class A Common Stock (DE)$1.64-5.20%$103.1M
VANIVivani Medical Inc. Common Stock (DE)$1.02+0.99%$92.0M
CNMDCONMED Corporation$49.35-2.45%$1.5B
STXSStereotaxis Inc.$0.8027-4.80%$80.4M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier